🌏We are pleased to invite you to check the highly cited Special Issues in 2022 in @Cancers_MDPI (ISSN: 2072-6694) on cancer drug development. We hope this announcement will provide useful information for this field👏
The Special Issues list is as follows: https://t.co/1PKxfQ5gGp
#SrbEVs members having a fantastic time learning, presenting and making a new conections at #SmallNewWorld. Thank you #ASEV, Wolfgang Holnthoner and Beate Rinner for inviting us and making this great meeting possible! 🤩🤩
A special issue on #glioblastoma therapeutic strategies in #mdpipharmaceutics invites submissions!
Guest Editor: Dr. Milica Pešić, Dr. Ana Podolski-Renić and Dr. Jelena Dinić
More info here: https://t.co/P5xP8bIyBV
🥳🥳🥳
#fondzanauku#TARGRES#programideje#IBISS#MFUB
We are so excited to announce that our new website is now live ✨
Visit it and learn more about the objectives of our project, team members, and more!
https://t.co/MhXIZzkH0k
Kick-off sastanak projekta #TargetedResponse! #fondzanauku#programideje
Dr Milica Pešić, naš glavni istraživač i rukovodilac Odeljenja za neurobiologiju IBISS-a, predstavila je projektne aktivnosti za naredni period.
Upoznajte naš tim!
https://t.co/I9qOtiQEDx
#mdpibrainsci Special Issue "At the Frontiers of Human Glioblastoma: Challenges in Introducing New Therapeutic Strategies" is open for submission https://t.co/mm6maFyrIg
Guest Editors: Dr. Milica Pešić, Dr. Pilar Sánchez Gómez and Dr. Lisa Oliver
submission deadline: 15 Jun 2021